HTC
SAGE

Hershey Trust Company’s Sage Therapeutics SAGE Stock Holding History

Hershey Trust Company’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-1,887
Closed -$118K – 19
2017
Q3 		$118K Buy
+1,887
New +$148K ﹤0.01% 11
2017
Q1 		– Sell
-66,487
Closed -$3.4M – 18
2016
Q4 		$3.4M Hold
66,487
– – 0.04% 3
2016
Q3 		$3.06M Buy
66,487
+7,547
+13% +$307K 0.04% 3
2016
Q2 		$1.78M Hold
58,940
– – 0.02% 3
2016
Q1 		$1.89M Hold
58,940
– – 0.03% 3
2015
Q4 		$3.44M Buy
58,940
+19,920
+51% +$987K 0.05% 3
2015
Q3 		$1.65M Buy
39,020
+27,303
+233% +$1.68M 0.02% 3
2015
Q2 		$855K Buy
+11,717
New +$753K 0.01% 7

Other funds holding SAGE

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Hershey Trust Company's SAGE Position: Q4 2017 in Review

Hershey Trust Company sold out of Sage Therapeutics (SAGE) in Q4 2017, closing a stake of 1,887 shares — an estimated $118K sold.

Hershey Trust Company first reported a position in SAGE in Q2 2015 and held it in 8 quarters. The position peaked at $3.44M in Q4 2015. 224 funds tracked by Wall St. Rank hold SAGE as of Q4 2017.

  • Hershey Trust Company reported no remaining Sage Therapeutics position as of Q4 2017 after selling out during the quarter.
  • Hershey Trust Company sold 1,887 Sage Therapeutics shares in Q4 2017, an estimated $118K.
  • Hershey Trust Company first reported a position in Sage Therapeutics in Q2 2015 and held it in 8 quarters.
  • Hershey Trust Company's Sage Therapeutics position peaked at $3.44M in Q4 2015.
  • 224 funds tracked by Wall St. Rank held Sage Therapeutics as of Q4 2017.

Based on Hershey Trust Company's 13F filing for Q4 2017, filed 23 Jan 2018.